Genetics of Chronic Obstructive Pulmonary Disease

 

 Buy Article Permissions and Reprints

ABSTRACT

Variability in the susceptibility to develop chronic obstructive pulmonary disease (COPD) is related to both genetic and environmental factors. COPD is likely a genetically complex disease, but severe alpha 1-antitrypsin (AAT) deficiency [e.g., protease inhibitor (PI) Z] remains the only proven genetic risk factor for COPD. Even among PI Z individuals, substantial variability in lung function is observed, suggesting that genetic modifiers may influence the expression of lung disease in severe AAT deficiency. The variable development of COPD in smokers without alpha 1-antitrypsin deficiency and the familial aggregation of lung function measurements also suggest the presence of genetic influences on lung function growth and decline leading to COPD. Many candidate gene loci have been investigated as potential COPD genetic determinants by case-control genetic association studies. However, inconsistent results of these association studies have been frequent. Genetic heterogeneity and population stratification are two potential reasons for the conflicting findings between association studies. Linkage analysis studies have recently been published that may identify regions of the genome that contain COPD susceptibility genes. Future investigations of genetic influences in COPD should consider the use of family-based designs for association studies and the study of positional candidate genes within regions of linkage.

REFERENCES

• 1 Lopez A D, Murray C C. The global burden of disease, 1990-2020.  Nat Med . 1998;  4 1241-1243
  CrossrefPubMedGoogle Scholar
• 2 Burrows B, Knudson R J, Cline M G, Lebowitz M D. Quantitative relationships between cigarette smoking and ventilatory function.  Am Rev Respir Dis . 1977;  115 195-205
  PubMedGoogle Scholar
• 3 Larsson C. Natural history and life expectancy in severe alpha 1-antitrypsin deficiency, PI Z.  Acta Med Scand . 1978;  204 345-351
  PubMedGoogle Scholar
• 4 Eriksson S. Studies in alpha 1-antitrypsin deficiency.  Acta Med Scand Suppl . 1965;  432 1-85
  PubMedGoogle Scholar
• 5 Piitulainen E, Eriksson S. Decline in FEV₁ related to smoking status in individuals with severe alpha 1-antitrypsin deficiency (PI ZZ).  Eur Respir J . 1999;  13 247-251
  CrossrefPubMedGoogle Scholar
• 6 Silverman E K, Pierce J A, Province M A, Rao D C, Campbell E J. Variability of pulmonary function in alpha 1-antitrypsin deficiency: clinical correlates.  Ann Intern Med . 1989;  111 982-991
  PubMedGoogle Scholar
• 7 Silverman E K, Province M A, Campbell E J, Pierce J A, Rao D C. Variability of pulmonary function in alpha 1-antitrypsin deficiency: residual family resemblance beyond the effect of the PI locus.  Hum Hered . 1990;  40 340-355
  PubMedGoogle Scholar
• 8 Black L F, Kueppers F. Alpha 1-antitrypsin deficiency in nonsmokers.  Am Rev Respir Dis . 1978;  117 421-428
  PubMedGoogle Scholar
• 9 Piitulainen E, Tornling G, Eriksson S. Effect of age and occupational exposure to airway irritants on lung function in non-smoking individuals with alpha 1-antitrypsin deficiency (PI ZZ).  Thorax . 1997;  52 244-248
  CrossrefPubMedGoogle Scholar
• 10 Novoradovsky A, Brantly M L, Waclawiw M A. et al . Endothelial nitric oxide synthase as a potential susceptibility gene in the pathogenesis of emphysema in alpha 1-antitrypsin deficiency.  Am J Respir Cell Mol Biol . 1999;  20 441-447
  PubMedGoogle Scholar
• 11 Lieberman J, Winter B, Sastre A. Alpha 1-antitrypsin PI-types in 965 COPD patients.  Chest . 1986;  89 370-373
  CrossrefPubMedGoogle Scholar
• 12 Kauffmann F, Tager I B, Munoz A, Speizer F E. Familial factors related to lung function in children aged 6-10 years: results from the PAARC epidemiologic study.  Am J Epidemiol . 1989;  129 1289-1299
  PubMedGoogle Scholar
• 13 Devor E J, Crawford M H. Family resemblance for normal pulmonary function.  Ann Hum Biol . 1984;  11 439-448
  PubMedGoogle Scholar
• 14 Hubert H B, Fabsitz R R, Feinleib M, Gwinn C. Genetic and environmental influences on pulmonary function in adult twins.  Am Rev Respir Dis . 1982;  125 409-415
  PubMedGoogle Scholar
• 15 Redline S, Tishler P V, Lewitter F I, Tager I B, Munoz A, Speizer F E. Assessment of genetic and nongenetic influences on pulmonary function: a twin study.  Am Rev Respir Dis . 1987;  135 217-222
  PubMedGoogle Scholar
• 16 Williams C, Clymer, M. A Practical Treatise on the Diseases of the Respiratory Organs; Including Disease of the Larynx, Trachea, Lungs and Pleura. Philadelphia: Lea and Blanchard 1845
  Google Scholar
• 17 Hurst A. Familial emphysema.  Am Rev Respir Dis . 1959;  80 179
  PubMedGoogle Scholar
• 18 Wimpfheimer F. Familial emphysema.  Am Rev Respir Dis . 1961;  83 697
  PubMedGoogle Scholar
• 19 Larson R K, Barman M L. The familial occurrence of chronic obstructive pulmonary disease.  Ann Intern Med . 1965;  63 1001-1008
  PubMedGoogle Scholar
• 20 Hole B V, Wasserman K. Familial emphysema.  Ann Intern Med . 1965;  63 1009-1017
  PubMedGoogle Scholar
• 21 Larson R K, Barman M L, Kueppers F, Fudenberg H H. Genetic and environmental determinants of chronic obstructive pulmonary disease.  Ann Intern Med . 1970;  72 627-632
  PubMedGoogle Scholar
• 22 Cohen B H, Ball Jr C W, Brashears S. et al . Risk factors in chronic obstructive pulmonary disease (COPD).  Am J Epidemiol . 1977;  105 223-232
  PubMedGoogle Scholar
• 23 Higgins M, Keller J. Familial occurrence of chronic respiratory disease and familial resemblance in ventilatory capacity.  J Chronic Dis . 1975;  28 239-251
  CrossrefPubMedGoogle Scholar
• 24 Kueppers F, Miller R D, Gordon H, Hepper N G, Offord K. Familial prevalence of chronic obstructive pulmonary disease in a matched pair study.  Am J Med . 1977;  63 336-342
  CrossrefPubMedGoogle Scholar
• 25 Silverman E K, Chapman H A, Drazen J M. et al . Genetic epidemiology of severe, early-onset chronic obstructive pulmonary disease: risk to relatives for airflow obstruction and chronic bronchitis.  Am J Respir Crit Care Med . 1998;  157(6 pt 1) 1770-1778
  PubMedGoogle Scholar
• 26 McCloskey S C, Patel B D, Hinchliffe S J, Reid E D, Wareham N J, Lomas D A. Siblings of patients with severe chronic obstructive pulmonary disease have a significant risk of airflow obstruction.  Am J Respir Crit Care Med . 2001;  164(8 pt 1) 1419-1424
  PubMedGoogle Scholar
• 27 Silverman E K, Palmer L J. Case-control association studies for the genetics of complex respiratory diseases.  Am J Respir Cell Mol Biol . 2000;  22 645-648
  PubMedGoogle Scholar
• 28 Silverman E K, Palmer L J, Mosley J D. et al . Genomewide linkage analysis of quantitative spirometric phenotypes in severe early-onset chronic obstructive pulmonary disease.  Am J Hum Genet . 2002;  70 1229-1239
  CrossrefPubMedGoogle Scholar
• 29 Silverman E K, Mosley J D, Palmer L J. et al . Genome-wide linkage analysis of severe, early-onset chronic obstructive pulmonary disease: airflow obstruction and chronic bronchitis phenotypes.  Hum Mol Genet . 2002;  11 623-632
  CrossrefPubMedGoogle Scholar
• 30 Seersholm N, Wilcke J T, Kok-Jensen A, Dirksen A. Risk of hospital admission for obstructive pulmonary disease in alpha 1-antitrypsin heterozygotes of phenotype PI MZ.  Am J Respir Crit Care Med . 2000;  161 81-84
  PubMedGoogle Scholar
• 31 Sandford A J, Chagani T, Weir T D, Connett J E, Anthonisen N R, Pare P D. Susceptibility genes for rapid decline of lung function in the Lung Health Study.  Am J Respir Crit Care Med . 2001;  163 469-473
  CrossrefPubMedGoogle Scholar
• 32 Dahl M, Nordestgaard B G, Lange P, Vestbo J, Tybjaerg-Hansen A. Molecular diagnosis of intermediate and severe alpha 1-antitrypsin deficiency: MZ individuals with chronic obstructive pulmonary disease may have lower lung function than MM individuals.  Clin Chem . 2001;  47 56-62
  PubMedGoogle Scholar
• 33 Poller W, Meisen C, Olek K. DNA polymorphisms of the alpha 1-antitrypsin gene region in patients with chronic obstructive pulmonary disease.  Eur J Clin Invest . 1990;  20 1-7
  PubMedGoogle Scholar
• 34 Kalsheker N A, Watkins G L, Hill S, Morgan K, Stockley R A, Fick R B. Independent mutations in the flanking sequence of the alpha 1-antitrypsin gene are associated with chronic obstructive airways disease.  Dis Markers . 1990;  8 151-157
  PubMedGoogle Scholar
• 35 Sandford A J, Spinelli J J, Weir T D, Pare P D. Mutation in the 3' region of the alpha 1-antitrypsin gene and chronic obstructive pulmonary disease.  J Med Genet . 1997;  34 874-875
  PubMedGoogle Scholar
• 36 Benetazzo M G, Gile L S, Bombieri C. et al . Alpha 1-antitrypsin TAQ I polymorphism and alpha 1-antichymotrypsin mutations in patients with obstructive pulmonary disease.  Respir Med . 1999;  93 648-654
  CrossrefPubMedGoogle Scholar
• 37 Ohnishi K, Takagi M, Kurokawa Y, Satomi S, Konttinen Y T. Matrix metalloproteinase-mediated extracellular matrix protein degradation in human pulmonary emphysema.  Lab Invest . 1998;  78 1077-1087
  PubMedGoogle Scholar
• 38 Finlay G A, O'Driscoll L R, Russell K J. et al . Matrix metalloproteinase expression and production by alveolar macrophages in emphysema.  Am J Respir Crit Care Med . 1997;  156 240-247
  PubMedGoogle Scholar
• 39 Shapiro S D. Elastolytic metalloproteinases produced by human mononuclear phagocytes: potential roles in destructive lung disease.  Am J Respir Crit Care Med . 1994;  150(6 pt 2) S160-S164
  PubMedGoogle Scholar
• 40 Minematsu N, Nakamura H, Tateno H, Nakajima T, Yamaguchi K. Genetic polymorphism in matrix metalloproteinase-9 and pulmonary emphysema.  Biochem Biophys Res Commun . 2001;  289 116-119
  CrossrefPubMedGoogle Scholar
• 41 Joos L, He J Q, Shepherdson M B. et al . The role of matrix metalloproteinase polymorphisms in the rate of decline in lung function.  Hum Mol Genet . 2002;  11 569-576
  CrossrefPubMedGoogle Scholar
• 42 Hirano K, Sakamoto T, Uchida Y. et al . Tissue inhibitor of metalloproteinases-2 gene polymorphisms in chronic obstructive pulmonary disease.  Eur Respir J . 2001;  18 748-752
  CrossrefPubMedGoogle Scholar
• 43 Sandford A J, Chagani T, Weir T D, Pare P D. Alpha 1-antichymotrypsin mutations in patients with chronic obstructive pulmonary disease.  Dis Markers . 1998;  13 257-260
  PubMedGoogle Scholar
• 44 Ishii T, Matsuse T, Teramoto S. et al . Association between alpha 1-antichymotrypsin polymorphism and susceptibility to chronic obstructive pulmonary disease.  Eur J Clin Invest . 2000;  30 543-548
  CrossrefPubMedGoogle Scholar
• 45 Otterbein L E, Lee P J, Chin B Y. et al . Protective effects of heme oxygenase-1 in acute lung injury.  Chest . 1999;  116 (suppl 1) S61-S63
  CrossrefPubMedGoogle Scholar
• 46 Choi A M, Alam J. Heme oxygenase-1: function, regulation, and implication of a novel stress-inducible protein in oxidant-induced lung injury.  Am J Respir Cell Mol Biol . 1996;  15 9-19
  PubMedGoogle Scholar
• 47 Yamada N, Yamaya M, Okinaga S. et al . Microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with susceptibility to emphysema.  Am J Hum Genet . 2000;  66 187-195
  CrossrefPubMedGoogle Scholar
• 48 Smith C A, Harrison D J. Association between polymorphism in gene for microsomal epoxide hydrolase and susceptibility to emphysema.  Lancet . 1997;  350 630-633
  CrossrefPubMedGoogle Scholar
• 49 Yoshikawa M, Hiyama K, Ishioka S, Maeda H, Maeda A, Yamakido M. Microsomal epoxide hydrolase genotypes and chronic obstructive pulmonary disease in Japanese.  Int J Mol Med . 2000;  5 49-53
  PubMedGoogle Scholar
• 50 Yim J J, Park G Y, Lee C T. et al . Genetic susceptibility to chronic obstructive pulmonary disease in Koreans: combined analysis of polymorphic genotypes for microsomal epoxide hydrolase and glutathione S-transferase M1 and TI.  Thorax . 2000;  55 121-125
  CrossrefPubMedGoogle Scholar
• 51 Takeyabu K, Yamaguchi E, Suzuki I, Nishimura M, Hizawa N, Kamakami Y. Gene polymorphism for microsomal epoxide hydrolase and susceptibility to emphysema in a Japanese population.  Eur Respir J . 2000;  15 891-894
  CrossrefPubMedGoogle Scholar
• 52 Harrison D J, Cantlay A M, Rae F, Lamb D, Smith C A. Frequency of glutathione S-transferase M1 deletion in smokers with emphysema and lung cancer.  Hum Exp Toxicol . 1997;  16 356-360
  CrossrefPubMedGoogle Scholar
• 53 Baranova H, Perriot J, Albuisson E. et al . Peculiarities of the GSTM1 0/0 genotype in French heavy smokers with various types of chronic bronchitis.  Hum Genet . 1997;  99 822-826
  CrossrefPubMedGoogle Scholar
• 54 Ishii T, Matsuse T, Teramoto S. et al . Glutathione S-transferase P1 (GSTP1) polymorphism in patients with chronic obstructive pulmonary disease.  Thorax . 1999;  54 693-696
  CrossrefPubMedGoogle Scholar
• 55 Bouma G, Crusius J B, Oudkerk P ool. et al . Secretion of tumour necrosis factor alpha and lymphotoxin alpha in relation to polymorphisms in the TNF genes and HLA-DR alleles: relevance for inflammatory bowel disease.  Scand J Immunol . 1996;  43 456-463
  CrossrefPubMedGoogle Scholar
• 56 Huang S L, Su C H, Chang S C. Tumor necrosis factor-alpha gene polymorphism in chronic bronchitis.  Am J Respir Crit Care Med . 1997;  156 1436-1439
  CrossrefPubMedGoogle Scholar
• 57 Sakao S, Tatsumi K, Igari H, Shino Y, Shirasawa H, Kuriyama T. Association of tumor necrosis factor alpha gene promoter polymorphism with the presence of chronic obstructive pulmonary disease.  Am J Respir Crit Care Med . 2001;  163 420-422
  CrossrefPubMedGoogle Scholar
• 58 Keatings V M, Cave S J, Henry M J. et al . A polymorphism in the tumor necrosis factor-alpha gene promoter region may predispose to a poor prognosis in COPD.  Chest . 2000;  118 971-975
  CrossrefPubMedGoogle Scholar
• 59 Ishii T, Matsuse T, Teramoto S. et al . Neither IL-1beta, IL-1 receptor antagonist, nor TNF-alpha polymorphisms are associated with susceptibility to COPD.  Respir Med . 2000;  94 847-851
  PubMedGoogle Scholar
• 60 Higham M A, Pride N B, Alikhan A, Morrell N W. Tumour necrosis factor-alpha gene promoter polymorphism in chronic obstructive pulmonary disease.  Eur Respir J . 2000;  15 281-284
  CrossrefPubMedGoogle Scholar
• 61 Joost O, Wilk J B, Cupples L A. et al . Genetic loci influencing lung function: a genome-wide scan in the Framingham Study.  Am J Respir Crit Care Med . 2002;  165 795-799
  PubMedGoogle Scholar
• 62 Lander E, Kruglyak L. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results.  Nat Genet . 1995;  11 241-247
  CrossrefPubMedGoogle Scholar
• 63 Bartmann K, Fooke-Achterrath M, Koch G. et al . Heterozygosity in the PI-system as a pathogenetic cofactor in chronic obstructive pulmonary disease (COPD).  Eur J Respir Dis . 1985;  66 284-296
  PubMedGoogle Scholar
• 64 Janus E D. Alpha 1-antitrypsin PI types in COPD patients.  Chest . 1988;  94 446-447
  PubMedGoogle Scholar
• 65 Sandford A J, Weir T D, Spinelli J J, Pare P D. Z and S mutations of the alpha 1-antitrypsin gene and the risk of chronic obstructive pulmonary disease.  Am J Respir Cell Mol Biol . 1999;  20 287-291
  PubMedGoogle Scholar
• 66 Cantlay A M, Smith C A, Wallace W A, Yap P L, Lamb D, Harrison D J. Heterogeneous expression and polymorphic genotype of glutathione S-transferases in human lung.  Thorax . 1994;  49 1010-1014
  PubMedGoogle Scholar
• 67 Sundberg K, Johansson A S, Stenberg G. et al . Differences in the catalytic efficiencies of allelic variants of glutathione transferase P1-1 towards carcinogenic diol epoxides of polycyclic aromatic hydrocarbons.  Carcinogenesis . 1998;  19 433-436
  CrossrefPubMedGoogle Scholar
• 68 Patuzzo C, Gile L S, Zorzetto M. et al . Tumor necrosis factor gene complex in COPD and disseminated bronchiectasis.  Chest . 2000;  117 1353-1358
  CrossrefPubMedGoogle Scholar
• 69 Teramoto S, Ishii T. No association of tumor necrosis factor-alpha gene polymorphism and COPD in Caucasian smokers and Japanese smokers.  Chest . 2001;  119 315-316
  CrossrefPubMedGoogle Scholar
• 70 Tzetis M, Efthymiadou A, Strofalis S. et al . CFTR gene mutations-including three novel nucleotide substitutions-and haplotype background in patients with asthma, disseminated bronchiectasis and chronic obstructive pulmonary disease.  Hum Genet . 2001;  108 216-221
  CrossrefPubMedGoogle Scholar
• 71 Ho L I, Harn H J, Chen C J, Tsai N M. Polymorphism of the beta-adrenoceptor in COPD in Chinese subjects.  Chest . 2001;  120 1493-1499
  CrossrefPubMedGoogle Scholar
• 72 Matsushita I, Hasegawa K, Nakata K, Yasuda K, Tokunaga K, Keicho N. Genetic variants of human beta-defensin-1 and chronic obstructive pulmonary disease.  Biochem Biophys Res Commun . 2002;  291 17-22
  CrossrefPubMedGoogle Scholar
• 73 Landi M T, Bertazzi P A, Shields P G. et al . Association between CYP1A1 genotype, mRNA expression and enzymatic activity in humans.  Pharmacogenetics . 1994;  4 242-246
  PubMedGoogle Scholar
• 74 Horne S L, Cockcroft D W, Dosman J A. Possible protective effect against chronic obstructive airways disease by the GC2 allele.  Hum Hered . 1990;  40 173-176
  CrossrefPubMedGoogle Scholar
• 75 Schellenberg D, Pare P D, Weir T D, Spinelli J J, Walker B A, Sandford A J. Vitamin D binding protein variants and the risk of COPD.  Am J Respir Crit Care Med . 1998;  157(3 pt 1) 957-961
  CrossrefPubMedGoogle Scholar
• 76 Kauffmann F, Kleisbauer J P, Cambon-De-Mouzon A. et al . Genetic markers in chronic air-flow limitation: a genetic epidemiologic study.  Am Rev Respir Dis . 1983;  127 263-269
  PubMedGoogle Scholar
• 77 Sugiyama Y, Kudoh S, Maeda H, Suzaki H, Takaku F. Analysis of HLA antigens in patients with diffuse panbronchiolitis.  Am Rev Respir Dis . 1990;  141 1459-1462
  CrossrefPubMedGoogle Scholar
• 78 Keicho N, Tokunaga K, Nakata K. et al . Contribution of HLA genes to genetic predisposition in diffuse panbronchiolitis.  Am J Respir Crit Care Med . 1998;  158 846-850
  CrossrefPubMedGoogle Scholar
• 79 Vestbo J, Hein H O, Suadicani P, Sorensen H, Gyntelberg F. Genetic markers for chronic bronchitis and peak expiratory flow in the Copenhagen Male Study.  Dan Med Bull . 1993;  40 378-380
  PubMedGoogle Scholar